IMGN

IMMUNOGEN INC Financials

moreView todays social media effects on IMGNView the latest stocks trending across Twitter. Click to view dashboardSee who ImmunoGen is hiring next, click here to view […]

ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences

[Business Wire] – ImmunoGen, Inc. , a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate technology, today announced that the fol moreView todays social media effects on IMGNView the latest stocks trending across Twitter. Click to view dashboardSee who ImmunoGen is hiring next, click here to view […]

4:15 pm Immunogen announces first clinical findings with refined dosing strategy for IMGN853: Initial Findings Show New Dosing Approach for IMGN853 Achieves Objective

moreView todays social media effects on IMGNView the latest stocks trending across Twitter. Click to view dashboardSee who ImmunoGen is hiring next, click here to view […]

ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences

[Business Wire] – ImmunoGen, Inc. , a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate technology, today announced that the fol moreView todays social media effects on IMGNView the latest stocks trending across Twitter. Click to view dashboardSee who ImmunoGen is hiring next, click here to view […]

ImmunoGen, Inc. Appoints Ellie Harrison as Chief Human Resources Officer

[Business Wire] – ImmunoGen, Inc. , a biotechnology company that develops targeted anticancer therapies using its antibody-drug conjugate technology, today announced the appointment of Ellie Harrison as Vice President and Chief Human Resources Officer. moreView todays social media effects on IMGNView the latest stocks trending across Twitter. Click to view dashboardSee who ImmunoGen is hiring next, click here to view […]

Monro Announces Dividend and New Board Member

[at noodls] – CONTACT: John Van Heel Chief Executive Officer (585) 647-6400 Robert Gross Executive Chairman (585) 647-6400 Catherine D’Amico Executive Vice President – Finance Chief Financial Officer (585) 647-6400 … moreView todays social media effects on IMGNView the latest stocks trending across Twitter. Click to view dashboardSee who ImmunoGen is hiring next, click here to view […]